Clark James David's Form 4 filing
CVS Health Corp (CVS) · filed Aug 4, 2023
- Accession no.
- 0001127602-23-022036
- Filed
- Aug 4, 2023
- Trade date
- Aug 3, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $1.93M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Clark James DavidCIK 0001757584 | Officer (SVP, Cont & Chief Acct Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Weighted average sales price; shares sold at a range of 74.79 to 74.80 per share.
Referenced by the price of 1 transaction in Table I.
- F2
Weighted average sales price; shares sold at a range of 74.90 to 75.02 per share.
Referenced by the price of 1 transaction in Table I.